Shan-shan Liu

Guangdong Provincial Key Laboratory Of Major Obstetric Diseases
Guangzhou, 510000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

A network pharmacological target mendelian randomization study on the neuroprotective effects of active ingredients in mahuang fuzi xixin decoction for multiple sclerosis.

A network pharmacological target mendelian randomization study on the neuroprotective effects of active ingredients in mahuang fuzi xixin decoction for multiple sclerosis.

Journal: Journal of Asian natural products research

Published: April 21, 2025

Targeting cell-state plasticity driven by FOXM1/CEBPB axis disrupts developmental heterogeneity and therapeutic resistance in hepatocellular carcinoma.

Targeting cell-state plasticity driven by FOXM1/CEBPB axis disrupts developmental heterogeneity and therapeutic resistance in hepatocellular carcinoma.

Journal: Journal of hepatology

Published: November 04, 2024

Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.

Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.

Journal: Journal of experimental & clinical cancer research : CR

Published: July 08, 2020

Identification of prognostic claudins signature in hepatocellular carcinoma from a hepatocyte differentiation model.

Identification of prognostic claudins signature in hepatocellular carcinoma from a hepatocyte differentiation model.

Journal: Hepatology international

Published: November 05, 2019

Development of an oncogenic dedifferentiation SOX signature with prognostic significance in hepatocellular carcinoma.

Development of an oncogenic dedifferentiation SOX signature with prognostic significance in hepatocellular carcinoma.

Journal: BMC cancer

Published: January 04, 2019

Transcatheter hepatic arterial infusion chemotherapy vs sorafenib in the treatment of patients with hepatocellular carcinoma of Barcelona Clinic Liver Cancer stage C: a meta-analysis of Asian population.

Transcatheter hepatic arterial infusion chemotherapy vs sorafenib in the treatment of patients with hepatocellular carcinoma of Barcelona Clinic Liver Cancer stage C: a meta-analysis of Asian population.

Journal: OncoTargets and therapy

Published: November 23, 2018

A Novel Regulatory Axis, CHD1L-MicroRNA 486-Matrix Metalloproteinase 2, Controls Spermatogonial Stem Cell Properties.

A Novel Regulatory Axis, CHD1L-MicroRNA 486-Matrix Metalloproteinase 2, Controls Spermatogonial Stem Cell Properties.

Journal: Molecular and cellular biology

Published: July 16, 2018

Identification of CHD1L as an Important Regulator for Spermatogonial Stem Cell Survival and Self-Renewal.

Identification of CHD1L as an Important Regulator for Spermatogonial Stem Cell Survival and Self-Renewal.

Journal: Stem cells international

Published: September 28, 2016

Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma.

Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma.

Journal: World journal of gastroenterology

Published: December 11, 2012

Transarterial chemoembolization combined with percutaneous radiofrequency ablation versus TACE and PRFA monotherapy in the treatment for hepatocellular carcinoma: a meta-analysis.

Transarterial chemoembolization combined with percutaneous radiofrequency ablation versus TACE and PRFA monotherapy in the treatment for hepatocellular carcinoma: a meta-analysis.

Journal: Journal of cancer research and clinical oncology

Published: October 15, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026